High frequency of genes' promoter methylation, but lack Of BRAF V600E Mutation among Iranian colorectal cancer patients

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 819-825

  Naghibalhossaini, Fakhraddin ^a   Hosseini, Hamideh Mahmoodzadeh ^a   Mokarram, Pooneh ^a,b   Zamani, Mozhdeh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BRAF. KRAS; Colon cancer; Methylation

Indexed keywords

ADULT; APC2 GENE; ARTICLE; BRAF GENE; CLINICAL EVALUATION; CODON; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; E CADHERIN GENE; EPIGENETICS; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; P14ARF GENE; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; TUMOR GENE;

CADHERINS; COLORECTAL NEOPLASMS; CPG ISLANDS; CYTOSKELETAL PROTEINS; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 84855467617     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9388-5     Document Type: Article

References (31)

1. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R (2009) Epidemiology and molecular genetics of colorectal cancer in Iran: A review. Arch Iran Med 12:161-169
2. Fazeli MS, Adel MG, Lebaschi AH (2007) Colorectal carcinoma: A retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University. Dis Colon Rectum 50:990-995
3. Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50:113e30
4. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96:8681-8686 (Pubitemid 29354851)
5. Marais R, Marshall CJ (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv 27:101-125 (Pubitemid 26363825)
6. Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Iacopetta B (2006) BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 5:2
7. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954 (Pubitemid 34716871)
8. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418:934 (Pubitemid 34976022)
9. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR et al (2008) Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res 14:2560-2569
10. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-793 (Pubitemid 43980599)
11. English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD et al (2008) Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomark Prev 17:1774-1780
12. Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K et al (2004) Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22:4584-4594 (Pubitemid 41185126)
13. Kominami K, Nagasaka T, Cullings HM, Hoshizima N, Sasamoto H, Young J et al (2009) Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability. J Int Med Res 37:1038-1045
14. Auerkari EI (2006) Methylation of tumor suppressor genes p16 (INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42:5-13 (Pubitemid 41831516)
15. Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM et al (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3:1709-1723 (Pubitemid 47510263)
16. Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL et al (2009) Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 15:1155-1161
17. Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I et al (2002) Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol 198:442-449 (Pubitemid 35446997)
18. Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627
19. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A et al (2000) Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 21:2057-2064
20. Mokarram P, Naghibalhossaini F, Saberi Firoozi M, Hosseini SV, Izadpanah A, Salahi H et al (2008) Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumorspecific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status.World J Gastroenterol 14:3662-3671
21. Servomaa K, Kiuru A, Kosma VM, Hirvikoski P, Rytömaa T (2000) p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol 53:24-30 (Pubitemid 30075071)
22. Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR (2007) An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449:1073-1077 (Pubitemid 350014604)
23. Mokarram P, Kumar K, Brim H, Naghibalhossaini F, Saberifiroozi M, Nouraie M et al (2009) Distinct high-profile methylated genes in colorectal cancer. PLoS ONE 4:e7012
24. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E et al (2006) Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95:1101-1107 (Pubitemid 44606839)
25. Wheeler JM, Kim HC, Efstathiou JA, Ilyas M, Mortensen NJ, Bodmer WF (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48:367-371 (Pubitemid 32269565)
26. Strathdee G (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol 12:373-379
27. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruïne AP, Goldbohm RA et al (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res 63:3133-3137 (Pubitemid 36735864)
28. Naghibalhossaini F, Mokarram P, Khalili I, Vasei M, Hosseini SV, Ashktorab H et al (2010) MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer Genet Cytogenet 197:142-151
29. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C et al (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62:6451-6455 (Pubitemid 35364105)
30. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9:305-314 (Pubitemid 47305066)
31. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al- Mandhari M, Al-Mawaly K et al (2008) Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer 7:68